ArticleNature immunology2022
An immunodominant NP
Open access · hybridAbstract read
In one paragraph
Article in Nature immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
128 citing papers in PubMed, 2 syntheses or guidelines pooled it, 181 citations in OpenAlex.
- The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis.Reviews in medical virology · 2023Pooled it
- Resolving SARS-CoV-2 CD4Cell reports. Medicine · 2022Pooled it
- Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.Nature communications · 2024Trial
- Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity.Frontiers in immunology · 2022Trial
- Cognition-Linked Monocyte State Reveals Altered Myeloid-Lymphoid Coordination in Neuro-PASC.International journal of molecular sciences · 2026Article
- The ageing immune system and its battle with viruses.The Journal of general virology · 2026Review
- The challenge and promise of studying human antigen-specific T cells.Nature reviews. Immunology · 2026Review
- Heterogeneity and dynamics of DENV-specific CD8 + T cells in dengue infection.Nature communications · 2026Article
- Comprehensive longitudinal profiling identifies differential frequency, epitope specificity, and effector function of CD8EBioMedicine · 2026Article
- Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026Article
- Protocol for stable cell line production to express muscle-type nicotinic receptor.STAR protocols · 2026Article
- Nucleocapsid protein enhances spike- and RBD-specific humoral and cellular immune responses in protein-based SARS-CoV-2 vaccine.BMC infectious diseases · 2026Article
- Resistance potential of the HLA-A2-restricted immunodominant SARS-CoV-2-specific CD8Nature communications · 2025Article
- Structural insights into clonal restriction and diversity in T cell recognition of two immunodominant SARS-CoV-2 nucleocapsid epitopes.Nature communications · 2025Article
- Limited vaccine-induced CD8+ T cell immunity in HIV-infected immunological nonresponders.JCI insight · 2025Article
- Identification of antigen-specific functional CD8iScience · 2025Article
- Long-persisting SARS-CoV-2 spike-specific CD4Nature communications · 2025Article
- HLA-B*15:01-positive severe COVID-19 patients lack CD8Proceedings of the National Academy of Sciences of the United States of America · 2025Article
- Molecular basis of potent antiviral HLA-C-restricted CD8Nature communications · 2025Article
- Tumor-specific CD8 T cell characterization in HRCell reports. Medicine · 2025Article
68 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
67 authors at 9 institutions in 4 countries.
Yanchun Peng *MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-2340-0499
Suet Ling Felce *Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Danning Dong *MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Frank Penkava *Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-9163-8576
Alexander J Mentzer *Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-4502-2209
Xuan Yao *Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Guihai Liu *Chinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Zixi Yin *MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2044-5838
Ji-Li Chen *MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Yongxu LuDepartment of Pathology, University of Cambridge, Cambridge, UK.
Dannielle WellingtonMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Peter A C WingChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2354-3281
Delaney C C Dominey-FoyChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Chen JinChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Wenbo WangChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Megat Abd HamidChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Ricardo A FernandesChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Beibei WangChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Anastasia FriesWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-1609-5991
Xiaodong ZhuangNuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6870-9003
Neil AshleySingle Cell Facility, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Timothy RostronSequencing Facility, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Craig WaughFlow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Paul SoppFlow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Philip HublitzGenome Engineering Facility, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8810-3247
Ryan BeveridgeVirus Screening Facility, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Tiong Kit TanMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8746-8308
Christina DoldOxford Vaccine Group, Department of Paediatrics, and NIHR Oxford Biomedical Research Centre, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, UK.
Andrew J KwokWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8928-5054
Charlotte Rich-GriffinWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0001-8212-9542
Wanwisa DejnirattisaWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Chang LiuChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Prathiba KurupatiMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Isar NassiriWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Robert A WatsonDepartment of Oncology, University of Oxford, Oxford, UK.
Orion TongDepartment of Oncology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-0659-5944
Chelsea A TaylorDepartment of Oncology, University of Oxford, Oxford, UK.
Piyush Kumar SharmaDepartment of Oncology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6247-3503
Bo SunWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-5507-6657
Fabiola CurionWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Santiago RevaleWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Lucy C GarnerMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6461-252X
Kathrin JansenKennedy Institute for Rheumatology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3803-7680
Ricardo C FerreiraWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Moustafa AttarKennedy Institute for Rheumatology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4116-1276
Jeremy W FryProImmune Limited, Oxford, UK.ORCID http://orcid.org/0000-0003-3689-6606
Rebecca A RussellSir William Dunn School of Pathology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6517-6483
COMBAT Consortium
Hans J StaussInstitute of Immunity and Transplantation, University College London, London, UK.ORCID http://orcid.org/0000-0003-4340-7911
William JamesJames & Lillian Martin Centre, Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-2506-1198
Alain TownsendMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Ling-Pei HoMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Paul KlenermanTranslational Gastroenterology Unit, Nuffield Department of Medicine, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4307-9161
Juthathip MongkolsapayaChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-3416-9480
Gavin R ScreatonChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-3549-4309
Calliope DendrouWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Stephen N SansomKennedy Institute for Rheumatology, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4569-8513
Rachael Bashford-RogersWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0002-6838-0711
Benny ChainDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0002-7417-3970
Geoffrey L SmithDepartment of Pathology, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-3730-9955
Jane A McKeatingChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Benjamin P FairfaxDepartment of Oncology, University of Oxford, Oxford, UK.
Paul BownessNuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.ORCID http://orcid.org/0000-0003-4597-0484
Andrew J McMichaelChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK.
Graham OggMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Julian C KnightChinese Academy of Medical Science Oxford Institute, University of Oxford, Oxford, UK. julian.knight@well.ox.ac.uk.
Tao DongMRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. tao.dong@imm.ox.ac.uk.ORCID http://orcid.org/0000-0003-3545-3758
University of Oxford · GBCentre for Human Genetics · GBNuffield Orthopaedic Centre · GBUniversity College London · GBUniversity of Cambridge · GBCapital Medical University · CNProImmune (United Kingdom) · GBSiriraj Hospital · THXinjiang Medical University · CN
Funding
Medical Research Council G0501329Medical Research Council G0600520Medical Research Council G1001046Medical Research Council MC_PC_20002Medical Research Council MC_UU_00008/11Medical Research Council MC_UU_00008/5Medical Research Council MR/L018942/1Medical Research Council MR/M00919X/1Medical Research Council MR/R022011/1Medical Research Council MR/V028502/1Versus Arthritis 22252Wellcome Trust 200838/Z/16/ZWellcome Trust 201488/Z/16/ZWellcome Trust 204969/Z/16/Z
Abstract
NP
Indexed as
AgedAmino Acid SequenceAntibodies, ViralAntibody AffinityCell Line, TransformedCOVID-19FemaleGene Expression ProfilingHLA-B7 AntigenHumansImmunodominant EpitopesImmunologic MemoryMaleMiddle AgedNucleocapsid ProteinsReceptors, Antigen, T-CellAntibodies, ViralHLA-B*07:02 antigenHLA-B7 AntigenImmunodominant EpitopesNucleocapsid ProteinsReceptors, Antigen, T-Cell
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.